Universe Pharmaceuticals INC (UPC)
USD 3.35
(-4.79%)
USD 3.35
(-4.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 197.2 Thousand USD | 111.11% |
| 2022 | -1.77 Million USD | 52.58% |
| 2021 | -3.74 Million USD | 49.5% |
| 2020 | -7.41 Million USD | -1030.73% |
| 2019 | -655.52 Thousand USD | 81.63% |
| 2018 | -3.56 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.35 Million USD | 0.0% |
| 2023 FY | 197.2 Thousand USD | 111.11% |
| 2023 Q4 | 197.2 Thousand USD | 0.0% |
| 2023 Q2 | -8.87 Million USD | 0.0% |
| 2022 FY | -1.77 Million USD | 52.58% |
| 2022 Q4 | -1.77 Million USD | 0.0% |
| 2022 Q2 | -9.82 Million USD | 0.0% |
| 2021 Q2 | -33.25 Million USD | 0.0% |
| 2021 FY | -3.74 Million USD | 49.5% |
| 2021 Q4 | -3.74 Million USD | 0.0% |
| 2020 FY | -7.41 Million USD | -1030.73% |
| 2020 Q4 | -7.41 Million USD | 0.0% |
| 2020 Q2 | -9.25 Million USD | 0.0% |
| 2019 FY | -655.52 Thousand USD | 81.63% |
| 2019 Q4 | -655.52 Thousand USD | 0.0% |
| 2018 FY | -3.56 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 99.955% |
| Embecta Corp. | 1.31 Billion USD | 99.985% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 99.791% |
| Dynavax Technologies Corporation | 106.63 Million USD | 99.815% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 99.957% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 99.954% |
| PainReform Ltd. | -7.95 Million USD | 102.481% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 99.737% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 101.261% |
| SCYNEXIS, Inc. | -19.35 Million USD | 101.019% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 102.091% |
| Cosmos Health Inc. | 8.59 Million USD | 97.704% |
| Journey Medical Corporation | -9.7 Million USD | 102.031% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 101.261% |
| Safety Shot Inc | -2.28 Million USD | 108.633% |
| Alpha Teknova, Inc. | 1.97 Million USD | 90.01% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 100.151% |
| Bright Green Corporation | 1.84 Million USD | 89.292% |
| Procaps Group, S.A. | 242.93 Million USD | 99.919% |
| Theratechnologies Inc. | 24.87 Million USD | 99.207% |
| Harrow Health, Inc. | 116.41 Million USD | 99.831% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 107.826% |
| Biofrontera Inc. | 4.05 Million USD | 95.138% |
| DURECT Corporation | -7.65 Million USD | 102.577% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 100.588% |
| Cronos Group Inc. | -663.32 Million USD | 100.03% |
| OptiNose, Inc. | 58.06 Million USD | 99.66% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 99.968% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 101.353% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 103.803% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 98.686% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 103.101% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -84.551% |
| Radius Health, Inc. | 359.28 Million USD | 99.945% |
| ProPhase Labs, Inc. | 19.23 Million USD | 98.975% |
| Phibro Animal Health Corporation | 454.84 Million USD | 99.957% |
| Procaps Group S.A. | 242.93 Million USD | 99.919% |
| Alvotech | 1.06 Billion USD | 99.981% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 94.638% |
| Viatris Inc. | 17.13 Billion USD | 99.999% |
| Rockwell Medical, Inc. | 4.45 Million USD | 95.574% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 104.044% |
| SIGA Technologies, Inc. | -148.68 Million USD | 100.133% |
| Tilray Brands, Inc. | 158.97 Million USD | 99.876% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 99.838% |
| Shineco, Inc. | 29.29 Million USD | 99.327% |
| PetIQ, Inc. | 351.93 Million USD | 99.944% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 106.797% |
| Incannex Healthcare Limited | -5.48 Million USD | 103.595% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 99.889% |
| Alimera Sciences, Inc. | 55.3 Million USD | 99.643% |
| Silver Spike Investment Corp. | -32.61 Million USD | 100.605% |
| Assertio Holdings, Inc. | -32.52 Million USD | 100.606% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 113.247% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 103.897% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 104.097% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 102.401% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 95.323% |
| Hempacco Co., Inc. | 13.61 Million USD | 98.551% |
| Talphera, Inc. | -5.72 Million USD | 103.447% |
| Alvotech | 1.06 Billion USD | 99.981% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 97.24% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 100.204% |
| Currenc Group, Inc. | -16.57 Million USD | 101.19% |
| Kamada Ltd. | -46.43 Million USD | 100.425% |
| Indivior PLC | -33.95 Million USD | 100.581% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 24.317% |
| Flora Growth Corp. | -713 Thousand USD | 127.659% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 102.401% |
| Evolus, Inc. | 63.7 Million USD | 99.69% |
| HUTCHMED (China) Limited | -197.45 Million USD | 100.1% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 99.959% |
| Akanda Corp. | 3.9 Million USD | 94.95% |